EVANGELISTI, CAMILLA
EVANGELISTI, CAMILLA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Docenti di ruolo di IIa fascia
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES
2014 Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D; Evangelisti C; Martelli AM
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia.
2010 F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli.
Advances in Targeting Signal Transduction Pathways.
2012 J.A. McCubrey; L.S. Steelman; W.H. Chappell; L. Sun; N.M. Davis; S.L. Abrams; R.A. Franklin; L. Cocco; C. Evangelisti; F. Chiarini; A.M. Martelli; M. Libra; S. Candido; G. Ligresti; G. Malaponte; M.C. Mazzarino; P. Fagone; M. Donia; F. Nicoletti; J. Polesel; R. Talamini; J. Bäsecke; S. Mijatovic; D. Maksimovic-Ivanic; M. Milella; A. Tafuri; J. Dulińska-Litewka; P. Laidler; A. B. D’Assoro; L. Drobot ; K. Umezawa; G. Montalto; M. Cervello; Z. N. Demidenko.
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting.
2016 Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; Neri, LM; McCubrey, Ja; Martelli, AM.
Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells.
2019 F. Charini, C. Evangelisti, G. Lattanzi, J.A. McCubrey, A.M. Martelli.
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy
2008 McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S.L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S.
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014 Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014 Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Bressanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am
Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
2014 C. Evangelisti; C. Evangelisti; G. Teti; F. Chiarini; M. Falconi; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; D. J. Beak; R. Bittman; S. Pyne; N.J. Pyne; A.M. Martelli.
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications.
2015 Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli.
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients?
2020 Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C.
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer.
2020 C. Evangelisti, F. Chiarini, F. Paganelli, S. Marmiroli, Alberto M. Martelli.
Cutting edge: the role of mTOR signaling in laminopathies.
2019 F. Chiarini, C. Evangelisti, V. Cenni, A. Fazio, F. Paganelli, A. M. Martelli, G. Lattanzi.
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
2014 F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli.
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.
2012 Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM.
Desmin and Plectin Recruitment to the Nucleus and Nuclei Orientation Are Lost in Emery-Dreifuss Muscular Dystrophy Myoblasts Subjected to Mechanical Stimulation
2024 Vittoria Cenni, Camilla Evangelisti, Spartaco Santi, Patrizia Sabatelli, Simona Neri, Marco Cavallo, Giovanna Lattanzi, Elisabetta Mattioli
DGKζ is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry.
2012 M. Okada; Y. Hozumi; T. Tanaka; Y. Suzuki; M. Yanagida; Y. Araki; C. Evangelisti; H. Yagisawa; M.K. Topham; A.M. Martelli; K. Goto
Elevated tgf b2 serum levels in emery-dreifuss muscular dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes
2018 Bernasconi P.; Carboni N.; Ricci G.; Siciliano G.; Politano L.; Maggi L.; Mongini T.; Vercelli L.; Rodolico C.; Biagini E.; Boriani G.; Ruggiero L.; Santoro L.; Schena E.; Prencipe S.; Evangelisti C.; Pegoraro E.; Morandi L.; Columbaro M.; Lanzuolo C.; Sabatelli P.; Cavalcante P.; Cappelletti C.; Bonne G.; Muchir A.; Lattanzi G.
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders
2023 Fazio, Antonietta; Evangelisti, Camilla; Cappellini, Alessandra; Mongiorgi, Sara; Koufi, Foteini-Dionysia; Neri, Irene; Marvi, Maria Vittoria; Russo, Michele; Ghigo, Alessandra; Manzoli, Lucia; Fiume, Roberta; Ratti, Stefano
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms.
2010 A.M. Martelli; V. Papa; P.L. Tazzari; F. Ricci; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Cappellini; G. Martinelli; E. Ottaviani; P. Pagliaro; S. Horn; J. Bäsecke; L.H. Lindner; H. Eibl; J.A. McCubrey.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES |
Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D...; Evangelisti C; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. | F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. ...Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli. | 2010-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Advances in Targeting Signal Transduction Pathways. | J.A. McCubrey; L.S. Steelman; W.H. Chappell; L. Sun; N.M. Davis; S.L. Abrams; R.A. Franklin; L. C...occo; C. Evangelisti; F. Chiarini; A.M. Martelli; M. Libra; S. Candido; G. Ligresti; G. Malaponte; M.C. Mazzarino; P. Fagone; M. Donia; F. Nicoletti; J. Polesel; R. Talamini; J. Bäsecke; S. Mijatovic; D. Maksimovic-Ivanic; M. Milella; A. Tafuri; J. Dulińska-Litewka; P. Laidler; A. B. D’Assoro; L. Drobot ; K. Umezawa; G. Montalto; M. Cervello; Z. N. Demidenko. | 2012-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. | Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; ...Neri, LM; McCubrey, Ja; Martelli, AM. | 2016-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells. | F. Charini, C. Evangelisti, G. Lattanzi, J.A. McCubrey, A.M. Martelli. | 2019-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy | McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S....L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S. | 2008-01-01 | - | Elsevier Ltd. | 2.01 Capitolo / saggio in libro | - |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS |
Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin... D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS | Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Br...essanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am | 2014-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. | C. Evangelisti; C. Evangelisti; G. Teti; F. Chiarini; M. Falconi; F. Melchionda; A. Pession; A. B...ertaina; F. Locatelli; J.A. McCubrey; D. J. Beak; R. Bittman; S. Pyne; N.J. Pyne; A.M. Martelli. | 2014-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. | Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontem...po; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli. | 2015-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| B-all complexity: Is targeted therapy still a valuable approach for pediatric patients? | Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-03498-v3(1).pdf |
| Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer. | C. Evangelisti, F. Chiarini, F. Paganelli, S. Marmiroli, Alberto M. Martelli. | 2020-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Cutting edge: the role of mTOR signaling in laminopathies. | F. Chiarini, C. Evangelisti, V. Cenni, A. Fazio, F. Paganelli, A. M. Martelli, G. Lattanzi. | 2019-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | The Cutting Edge.pdf |
| Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling | F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evan...gelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli. | 2014-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. | Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari... PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM. | 2012-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Desmin and Plectin Recruitment to the Nucleus and Nuclei Orientation Are Lost in Emery-Dreifuss Muscular Dystrophy Myoblasts Subjected to Mechanical Stimulation | Vittoria Cenni, Camilla Evangelisti, Spartaco Santi, Patrizia Sabatelli, Simona Neri, Marco Caval...lo, Giovanna Lattanzi, Elisabetta Mattioli | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | cells-13-00162.pdf |
| DGKζ is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry. | M. Okada; Y. Hozumi; T. Tanaka; Y. Suzuki; M. Yanagida; Y. Araki; C. Evangelisti; H. Yagisawa; M....K. Topham; A.M. Martelli; K. Goto | 2012-01-01 | CELLULAR SIGNALLING | - | 1.01 Articolo in rivista | - |
| Elevated tgf b2 serum levels in emery-dreifuss muscular dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes | Bernasconi P.; Carboni N.; Ricci G.; Siciliano G.; Politano L.; Maggi L.; Mongini T.; Vercelli L....; Rodolico C.; Biagini E.; Boriani G.; Ruggiero L.; Santoro L.; Schena E.; Prencipe S.; Evangelisti C.; Pegoraro E.; Morandi L.; Columbaro M.; Lanzuolo C.; Sabatelli P.; Cavalcante P.; Cappelletti C.; Bonne G.; Muchir A.; Lattanzi G. | 2018-01-01 | NUCLEUS | - | 1.01 Articolo in rivista | - |
| Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders | Fazio, Antonietta; Evangelisti, Camilla; Cappellini, Alessandra; Mongiorgi, Sara; Koufi, Foteini-...Dionysia; Neri, Irene; Marvi, Maria Vittoria; Russo, Michele; Ghigo, Alessandra; Manzoli, Lucia; Fiume, Roberta; Ratti, Stefano | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-24-13096-v2.pdf |
| Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. | A.M. Martelli; V. Papa; P.L. Tazzari; F. Ricci; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Capp...ellini; G. Martinelli; E. Ottaviani; P. Pagliaro; S. Horn; J. Bäsecke; L.H. Lindner; H. Eibl; J.A. McCubrey. | 2010-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |